title: Little to learn from phase II trials in small-cell lung cancer.
authors.forename: S
authors.initials: S
authors.lastname: Leyvraz
authors.forename: R
authors.initials: R
authors.lastname: Stupp
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D015996:Survival Rate
chemical_list: D016298:Hematopoietic Cell Growth Factors